Relationship of Fuchs Endothelial Corneal Dystrophy Severity to Central Corneal Thickness

Relationship of Fuchs Endothelial Corneal Dystrophy Severity to Central Corneal Thickness

Interview with Jonathan H. Lass, MD, author of Relationship of Fuchs Endothelial Corneal Dystrophy Severity to Central Corneal Thickness

Episoder(125)

Retinoblastoma Incidence Patterns in the US Surveillance, Epidemiology, and End Results Program

Retinoblastoma Incidence Patterns in the US Surveillance, Epidemiology, and End Results Program

Interview with Jeannette R. Wong, MPH, author of Retinoblastoma Incidence Patterns in the US Surveillance, Epidemiology, and End Results Program

10 Apr 20145min

Effect of Bifocal and Prismatic Bifocal Spectacles on Myopia Progression in Children: Three-Year Results of a Randomized Clinical Trial

Effect of Bifocal and Prismatic Bifocal Spectacles on Myopia Progression in Children: Three-Year Results of a Randomized Clinical Trial

Interview with Desmond Cheng, OD, MSc, PhD, author of Effect of Bifocal and Prismatic Bifocal Spectacles on Myopia Progression in Children: Three-Year Results of a Randomized Clinical Trial

16 Jan 20146min

Functional Burden of Strabismus: Decreased Binocular Summation and Binocular Inhibition

Functional Burden of Strabismus: Decreased Binocular Summation and Binocular Inhibition

Interview with Stacy L. Pineles, MD, author of Functional Burden of Strabismus: Decreased Binocular Summation and Binocular Inhibition

14 Nov 20136min

Socioeconomic Disparity in Use of Eye Care Services Among US Adults With Age-Related Eye Diseases

Socioeconomic Disparity in Use of Eye Care Services Among US Adults With Age-Related Eye Diseases

Interview with Jinan Saaddine, MD, MPH, author of Socioeconomic Disparity in Use of Eye Care Services Among US Adults With Age-Related Eye Diseases

12 Sep 20138min

Lutein/Zeaxanthin for the Treatment of Age-Related Cataract: AREDS2 Randomized Trial Report No. 4

Lutein/Zeaxanthin for the Treatment of Age-Related Cataract: AREDS2 Randomized Trial Report No. 4

Interview with Emily Y. Chew, MD, author of Lutein/Zeaxanthin for the Treatment of Age-Related Cataract: AREDS2 Randomized Trial Report No. 4

11 Jul 20136min

Can We Stop Mass Drug Administration Prior to 3 Annual Rounds in Communities With Low Prevalence of Trachoma? PRET Ziada Trial Results

Can We Stop Mass Drug Administration Prior to 3 Annual Rounds in Communities With Low Prevalence of Trachoma? PRET Ziada Trial Results

Interview with Sheila K. West, PhD, author of Can We Stop Mass Drug Administration Prior to 3 Annual Rounds in Communities With Low Prevalence of Trachoma? PRET Ziada Trial Results

11 Apr 201311min

Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes

Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes

Interview with Johanna M. Seddon, MD, ScM, author of Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes

14 Feb 201311min

Risk Alleles in CFH and ARMS2 and the Long-term Natural History of Age-Related Macular Degeneration

Risk Alleles in CFH and ARMS2 and the Long-term Natural History of Age-Related Macular Degeneration

Interview with Ronald Klein, MD, MPH, author of Risk Alleles in CFH and ARMS2 and the Long-term Natural History of Age-Related Macular Degeneration

9 Nov 20126min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
rekommandert
forskningno
rss-nysgjerrige-norge
sinnsyn
rss-rekommandert
vett-og-vitenskap-med-gaute-einevoll
smart-forklart
pod-britannia
fjellsportpodden
liberal-halvtime
jss
villmarksliv
nevropodden
aldring-og-helse-podden
rss-overskuddsliv
psykopoden
tomprat-med-gunnar-tjomlid
dekodet-2